In-licensing / Out-licensing
What we do:
Black Diamond Therapeutics places a high value on partnering with companies and organizations whose strengths complement our own. Black Diamond is committed to partnering with innovators in the fight against cancer by providing transformational precision therapies to patients worldwide.
Our focus is on:
- Seeking global and regional partners for discovery, development, and commercialization of MasterKey therapeutics
- In-licensing opportunities at all development stages with a focus on innovative assets that target key oncogenic signaling pathways
- Clinical and research collaborations (including combinations) that broaden the potential of our internal programs